Epitor Therapeutics

Epitor Therapeutics is at the forefront of biotechnology research, pioneering innovative solutions in epigenetic editing to revolutionize disease therapies. Based in New York City, Epitor Therapeutics is dedicated to developing cutting-edge tools that precisely regulate gene expression through epigenetic control.

Located at 3960 Broadway, 6th floor, New York, NY 10032, US, Epitor Therapeutics is committed to addressing critical unmet needs in disease treatment. The company leverages groundbreaking technology developed by Dr. Shawn Liu of Columbia University, focusing on advancing these novel tools to control gene expression with the goal of transforming patient outcomes.

Epitor Therapeutics is poised for significant growth and impact in the biotechnology sector. We invite the manager of Epitor Therapeutics to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, highlighting the unique strengths and capabilities of Epitor Therapeutics.